Fundraising Fox

Astek Diagnostics

YC S21

Baltimore, US · Founded 2020 · Delaware corporation · 5 employees · 2 known investors

astekdx.com

Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMicrofluidicsin /company@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (S21)

CC
Courtney CavinCofounder30 Under 30 2026

Investors · 2

Reported raises · per SEC filings

Form D private placements
$750KraisedApr 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$750K
Minimum investment
$5K
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.1MraisedOct 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer
Offering amount
$2.5M
Amount sold
$1.1M
Minimum investment
$5K
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$345KraisedAug 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$345K
Amount sold
$345K
Minimum investment
$5K
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.4MraisedAug 2023 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.4M
Minimum investment
$5K
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$350KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$350K
Amount sold
$350K
Minimum investment
$5K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$150KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mustafa Al-AdhamiExecutive Officer, Director
Offering amount
$150K
Amount sold
$150K
Minimum investment
$5K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news